Proteome Analysis of Chronically Inflamed Lungs in a Mouse Chronic Asthma ModelWong W.S.F. · Zhao J.
Department of Pharmacology, Yong Loo Ling School of Medicine, and Immunology Program, Center for Life Sciences, National University of Singapore, Singapore
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background: Asthma is a chronic airway inflammatory disease characterized by airway wall remodeling. The mechanisms underlying airway remodeling in asthma are not fully understood. There is an urgent need to investigate global protein profiling of chronically inflamed lungs to identify novel pathogenic molecules and biomarkers for chronic asthma. In this study, we described the first differentially expressed proteome of lung tissue and bronchoalveolar lavage fluid from a mouse chronic asthma model. Methods: BALB/c mice sensitized to ovalbumin were challenged with ovalbumin aerosol 3 times per week for 8 weeks. The lung tissue and lavage fluid proteins were resolved by 2-dimensional gel electrophoresis, and differentially expressed proteins were identified by matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry. Results: Airway goblet cell hyperplasia, smooth muscle hyperplasia, subepithelial fibrosis, airway hyperresponsiveness, pulmonary inflammatory cell infiltration and elevated serum ovalbumin-specific IgE level were observed in our chronic asthma model. We have identified at least 100 protein spots that were differentially expressed in chronically inflamed lungs, and the identity of 66 protein spots was confirmed. Conclusions: Many of these proteins, including cytoskeleton-related proteins, Ca2+-binding proteins and anti-oxidant proteins, may be related to the development of airway remodeling, and they should be evaluated further as potential therapeutic targets and biomarkers for chronic asthma.
© 2008 S. Karger AG, Basel
- Pascual RM, Peters SP: Airway remodeling contributes to the progressive loss of lung function in asthma: an overview. J Allergy Clin Immunol 2005;116:477–486.
- Gono H, Fujimoto K, Kawakami S, Kubo K: Evaluation of airway wall thickness and air trapping by HRCT in asymptomatic asthma. Eur Respir J 2003;22:965–971.
- van den Toorn LM, Overbeek SE, Prins JB, Hoogsteden HC, de Jongste JC: Asthma remission: does it exist? Curr Opin Pulm Med 2003;9:15–20.
- Crameri R: The potential of proteomics and peptidomics for allergy and asthma research. Allergy 2005;60:1227–1237.
- Hirsch J, Hansen KC, Burlingame AL, Matthay MA: Proteomics: current techniques and potential applications to lung disease. Am J Physiol Lung Cell Mol Physiol 2004;287:L1–L23.
- Houtman R, Krijgsveld J, Kool M, Romijn EP, Redegeld FA, Nijkamp FP, Heck AJ, Humphery-Smith I: Lung proteome alterations in a mouse model for nonallergic asthma. Proteomics 2003;3:2008–2018.
- Zhao J, Zhu H, Wong CH, Leung KY, Wong WSF: Increased lungkine and chitinase levels in allergic airway inflammation: a proteomics approach. Proteomics 2005;5:2799–2807.
- Jeong H, Rhim T, Ahn MH, Yoon PO, Kim SH, Chung IY, Uh S, Kim SI, Park CS: Proteomic analysis of differently expressed proteins in a mouse model for allergic asthma. J Korean Med Sci 2005;20:579–585.
- Signor L, Tigani B, Beckmann N, Falchetto R, Stoeckli M: Two-dimensional electrophoresis protein profiling and identification in rat bronchoalveolar lavage fluid following allergen and endotoxin challenge. Proteomics 2004;4:2101–2110.
- Fajardo I, Svensson L, Bucht A, Pejler G: Increased levels of hypoxia-sensitive proteins in allergic airway inflammation. Am J Respir Crit Care Med 2004;170:477–484.
- Fehniger TE, Sato-Folatre JG, Malmstrom J, Berglund M, Lindberg C, Brange C, Lindberg H, Marko-Varga G: Exploring the context of the lung proteome within the airway mucosa following allergen challenge. J Proteome Res 2004;3:307–320.
- Fulkerson PC, Rothenberg ME, Hogan SP: Building a better mouse model: experimental models of chronic asthma. Clin Exp Allergy 2005;35:1251–1253.
- Kumar RK, Foster PS: Modeling allergic asthma in mice: pitfalls and opportunities. Am J Respir Cell Mol Biol 2002;27:267–272.
- Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK: An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax 1998;53:849–856.
- McMillan SJ, Lloyd CM: Prolonged allergen challenge in mice leads to persistent airway remodeling. Clin Exp Allergy 2004;34:497–507.
- Pitchford SC, Riffo-Vasquez Y, Sousa A, Momi S, Gresele P, Spina D, Page CP: Platelets are necessary for airway wall remodeling in a murine model of chronic allergic inflammation. Blood 2004;103:639–647.
- Sakai K, Yokoyama A, Kohno N, Hamada H, Hiwada K: Prolonged antigen exposure ameliorates airway inflammation but not remodeling in a mouse model of bronchial asthma. Int Arch Allergy Immunol 2001;126:126–134.
- Duan W, Chan JHP, Wong CH, Leung BP, Wong WSF: Anti-inflammatory effects of mitogen-activated protein kinase kinase inhibitor U0126 in an asthma mouse model. J Immunol 2004;172:7053–7059.
- Henderson WR Jr, Tang L, Chu S, Tsao S, Chiang GKS, Jones F, Jonas M, Pae C, Wang H, Chi EY: A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model. Am J Respir Crit Care Med 2002;165:108–116.
- Palmans E, Kips JC, Pauwels RA: Prolonged allergen exposure induces structural airway changes in sensitized rats. Am J Respir Crit Care Med 2000;161:627–635.
- Adler A, Cieslewicz G, Irvin CG: Unrestrained plethysmography is an unreliable measure of airway responsiveness in BALB/c and C57BL/6 mice. J Appl Physiol 2004;97:286–292.
- Graves PR, Haystead TA: Molecular biologist’s guide to proteomics. Microbiol Mol Biol Rev 2002;66:39–63.
- Zhu Z, Zheng T, Homer RJ, Kim YK, Chen NY, Cohn L, Hamid Q, Elias JA: Acidic mammalian chitinase in asthmatic Th2 inflammation and IL-13 pathway activation. Science 2004;304:1678–1682.
- Webb DC, McKenzie AN, Foster PS: Expression of the Ym2 lectin-binding protein is dependent on interleukin (IL)-4 and IL-13 signal transduction: identification of a novel allergy-associated protein. J Biol Chem 2001;276:41969–41976.
- Nair MG, Gallagher IJ, Taylor MD, Loke P, Coulson PS, Wilson RA, Maizels RM, Allen JE: Chitinase and Fizz family members are a generalized feature of nematode infection with selective upregulation of Ym1 and Fizz1 by antigen-presenting cells. Infect Immun 2005;73:385–394.
- Yamaji K, Su Q, Angelini DJ, Champion HC, Johns RA: Hypoxia-induced mitogenic factor has proangiogenic and proinflammatory effects in the lung via VEGF and VEGF receptor-2. Am J Physiol Lung Cell Mol Physiol 2006;291:L1159–L1168.
Liu T, Dhanasekaran SM, Jin H, Hu B, Tomlins SA, Chinnaiyan AM, Phan SH: FIZZ1 stimulation of myofibroblast differentiation. Am J Pathol 004;164:1315–1326.
- Ivetic A, Ridley AJ: Ezrin/radixin/moesin proteins and Rho GTPase signalling in leucocytes. Immunology 2004;112:165–176.
- Koss M, Pfeiffer GR II, Wang Y, Thomas ST, Yerukhimovich M, Gaarde WA, Doerschuk CM, Wang Q: Ezrin/radixin/moesin proteins are phosphorylated by TNF-α and modulate permeability increases in human pulmonary microvascular endothelial cells. J Immunol 2006;176:1218–1227.
- Samstag Y, Eibert SM, Klemke M, Wabnitz GH: Actin cytoskeletal dynamics in T lymphocyte activation and migration. J Leukoc Biol 2003;73:30–48.
- Fujibuchi T, Abe Y, Takeuchi T, Imai Y, Kamei Y, Murase R, Ueda N, Shigemoto K, Yamamoto H, Kito K: AIP1/WDR1 supports mitotic cell rounding. Biochem Biophys Res Commun 2005;327:268–275.
- Dos Remedios CG, Chhabra D, Kekic M, Dedova IV, Tsubakihara M, Berry DA, Nosworthy NJ: Actin binding proteins: regulation of cytoskeletal microfilaments. Physiol Rev 2003;83:433–473.
- Ambach A, Saunus J, Konstandin M, Wesselborg S, Meuer SC, Samstag Y: The serine phosphatases PP1 and PP2A associate with and activate the actin-binding protein cofilin in human T lymphocytes. Eur J Immunol 2000;30:3422–3431.
- Ikeda S, Fujimori M, Shibata S, Okajima M, Ishizaki Y, Kurihara T, Miyata Y, Iseki M, Shimizu Y, et al: Combined immunohistochemistry of beta-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer. BMC Cancer 2006;6:31.
- Nakanishi A, Morita S, Iwashita H, Sagiya Y, Ashida Y, Shirafuji H, Fujisawa Y, Nishimura O, Fujino M: Role of gob-5 in mucus overproduction and airway hyperresponsiveness in asthma. Proc Natl Acad Sci USA 2001;98:5175–5180.
- Gibson A, Lewis AP, Affleck K, Meidrum E, Thompson N: hCLCA1 and mCLCA3 are secreted non-integral membrane proteins and therefore are not ion channel. J Biol Chem 2005;280:27205–27212.
- Robichaud A, Tuck SA, Kargman S, Tam J, Wong E, Abramovitz M, Mortimer J, Burston HE, Masson P, Slipetz D, Kennedy B, O’Neill G, Xanthoudakis S: Gob-5 is not essential for mucus overproduction in preclinical murine models of allergic asthma. Am J Respir Cell Mol Biol 2005;33:303–314.
- Comhair SA, Ricci KS, Arroliga M, Lara AR, Dweik RA, Song W, Hazen SL, Bleecker ER, Busse WW, Chung KF, Gaston B, Hastie A, Hew M, Jarjour N, Moore W, Peters S, Teague WG, Wenzel SE, Erzurum SC: Correlation of systemic superoxide dismutase deficiency to airflow obstruction in asthma. Am J Respir Crit Care Med 2005;172:306–313.
- Comhair SA, Xu W, Ghosh S, Thunnissen FB, Almasan A, Calhoun WJ, Janocha AJ, Zheng L, Hazen SL, Erzurum SC: Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity. Am J Pathol 2005;166:663–674.
- Larsen GL, White CW, Takeda K, Loader JE, Nguyen DD, Joetham A, Groner Y, Gelfand EW: Mice that overexpress Cu/Zn superoxide dismutase are resistant to allergen-induced changes in airway control. Am J Physiol Lung Cell Mol Physiol 2000;279:L350–L359.
- Sunahori K, Yamamura M, Yamana J, Takasugi K, Kawashima M, Yamamoto H, Chazin WJ, Nakatori Y, Yui S, Makino H: The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis. Arthritis Res Ther 2006;8:R69.
- Cross SS, Hamdy FC, Deloulme JC, Rehman I: Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers. Histopathology 2005;46:256–269.
- Wu J, Kobayashi M, Sousa EA, Liu W, Cai J, Goldman SJ, Dorner AJ, Projan SJ, Kavuru MS, Qiu Y, Thomassen MJ: Differential proteomic analysis of bronchoalveolar lavage fluid in asthmatics following segmental antigen challenge. Mol Cell Proteomics 2005;4:1251–1264.
- Rahimi F, Hsu K, Endoh Y, Geczy CL: FGF-2, IL-1β and TGF-β regulate fibroblast expression of S100A8. FEBS J 2005;272:2811–2827.
- Xu K, Yen T, Geczy CL: IL-10 up-regulates macrophage expression of the S100 protein S100A8. J Immunol 2001;166:6358–6366.
- Hsu K, Passey RJ, Endoh Y, Rahimi F, Youssef P, Yen T, Geczy CL: Regulation of S100A8 by glucocorticoids. J Immunol 2005;174:2318–2326.
- van Heusden GP: 14-3-3 proteins: regulators of numerous eukaryotic proteins. IUBMB Life 2005;57:623–629.
- Gurusamy N, Watanabe K, Ma M, Zhang S, Muslin AJ, Kodama M, Aizawa Y: Inactivation of 14-3-3 protein exacerbates cardiac hypertrophy and fibrosis through enhanced expression of protein kinase Cβ2 in experimental diabetes. Biol Pharm Bull 2005;28:957–962.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.